ANN ARBOR ? Eight Life Sciences companies will pitch potential investors
at the 2005 Michigan Growth Capital Symposium June 15-16 at the University of Michigan Ross School of Business. The life sciences are one track of 32 presenting companies that include information technology and alternative energy.
“The MGCS is thrilled with the quality level of this year’s life sciences companies,” said Dr. David J. Brophy, director of the Center for Venture Capital and Private Equity Finance. “It’s a testament to the developing strength of the life sciences corridor in Michigan.”
Presenting companies in the field of life sciences include:
Afmedica, develops products to prevent the excess scarring that can occur inside blood vessels following vascular surgery and adhesions after other surgical procedures.
Careguide, brings the power of ethnography-the patient’s point of view, as scientifically determined – to healthcare and uncovers false assumptions providers have about the instructions they deliver to patients.
EraGen Biosciences, is a global molecular diagnostics and drug discovery company that is designing, developing, manufacturing and marketing the next generation of automated genetic testing products for early, accurate diagnosis of every disease.
HandyLab, is dedicated to the development and manufacture of novel diagnostic products based on its patented microfluidic technology.
Immunetrics, with a mission to become a leading company in inflammatory disease modeling, it leverages its technology to develop a pipeline of immunomodulatory drugs.
RedPath, provides specialized diagnostic testing services with its patented platform technology, PathFinderTG
.
Velcura Therapeutics, develops drug therapies that stimulate bone growth for the treatment of osteoporosis, fractures, and other bone disorders.
ZelleRx Corporation, is a biopharmaceutical company developing cancer treatment products based on its proprietary natural killer (NK) cell line, NK-92.
For more information, click on MichiganGCS.Com
